Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.71 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 4/20 | 0.56 |
| ▸ | PAM | P19021 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.51 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.51 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.51 |
| ▸ | NAAA | Q02083 | 1/20 | 0.50 |
| ▸ | PRKCA | P17252 | 1/20 | 0.50 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.50 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.50 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28455938 | 1.00 | DGKA (0.71) | DGKAMAPTDNM1LMNAPAM | |
| SCHEMBL1171845 | 1.00 | DGKA (0.71) | DGKAMAPTDNM1LMNAPAM | |
| SCHEMBL2396768 | 1.00 | DGKA (0.71) | DGKAMAPTDNM1LMNAPAM | |
| SCHEMBL37144 | 1.00 | DGKA (0.71) | DGKAMAPTDNM1LMNAPAM | |
| SCHEMBL21777496 | 1.00 | DGKA (0.71) | DGKAMAPTDNM1LMNAPAM | |
| SCHEMBL120186 | 1.00 | DGKA (0.71) | DGKAMAPTDNM1LMNAPAM | |
| SCHEMBL19409845 | 1.00 | DGKA (0.71) | DGKAMAPTDNM1LMNAPAM | |
| SCHEMBL2032699 | 1.00 | DGKA (0.71) | DGKAMAPTDNM1LMNAPAM | |
| SCHEMBL2397395 | 1.00 | DGKA (0.71) | DGKAMAPTDNM1LMNAPAM | |
| SCHEMBL28445535 | 1.00 | DGKA (0.71) | DGKAMAPTDNM1LMNAPAM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 629 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122075332-A | Composition, preparation method thereof and sun-screening composition | — | 2026-05-26 | — | — | CN | claimed |
| EP-4514146-B1 | A COMBINATION FOR USE IN THE PREPARATION OF A DRINKABLE FOAMING OR FOAMABLE LIQUID, A DEVICE AND A METHOD FOR PREPARING AND DISPENSING A DRINKABLE FOAMING OR FOAMABLE LIQUID | BAR ON B V (BE) | 2026-05-13 | — | — | EP | claimed |
| US-20260083652-A1 | RENEWABLE ESTER EMOLLIENT FOR ENHANCED CUTANEOUS PERMEATION | OXITENO S.A. INDÚSTRIA E COMÉRCIO (BR) | 2026-03-26 | — | — | US | claimed |
| US-20260028562-A1 | FLAVORED POROUS MATERIAL FOR FLAVORED BEVERAGE PRODUCTION | DANSTAR FERMENT AG (CH) | 2026-01-29 | — | — | US | claimed |
| US-12497561-B2 | Ink composition, organic light-emitting device using same, and manufacturing method therefor | LG CHEM, LTD. (KR) | 2025-12-16 | — | — | US | claimed |
| US-20250344991-A1 | COMPOSITIONS AND METHODS FOR A UNIVERSAL CLINICAL TEST FOR OLFACTORY DYSFUNCTION | UNIV ROCKEFELLER (US) | 2025-11-13 | — | — | US | claimed |
| EP-3648613-B1 | COMPOSITIONS AND METHODS FOR A UNIVERSAL CLINICAL TEST FOR OLFACTORY DYSFUNCTION | UNIV ROCKEFELLER (US) | 2025-09-24 | — | — | EP | claimed |
| EP-3094193-B1 | PROCESS FOR PRODUCING FLAVORANTS AND RELATED MATERIALS | REYNOLDS TOBACCO CO R (US) | 2025-09-03 | — | — | EP | claimed |
| EP-4608363-A1 | A COMPOSITION FOR IMPROVING EFFECTIVENESS OF DYE PRECURSORS FOR CHANGE OF COLOUR OF HAIR | Cavinkare Pvt. Ltd (IN) | 2025-09-03 | — | — | EP | claimed |
| EP-4557970-A1 | FLAVORED POROUS MATERIAL FOR FLAVORED BEVERAGE PRODUCTION | Danstar Ferment AG (CH) | 2025-05-28 | — | — | EP | claimed |
| US-7579495-B2 | Active-releasing cyclic siloxanes | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2009-08-25 | — | — | US | claimed |
| US-7576170-B2 | Cyclic siloxane compositions for the release of active ingredients | MOMENTIVE PERFORMANCE MATERIALS (US) | 2009-08-18 | — | — | US | claimed |
| EP-1697386-B1 | ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES | GEN ELECTRIC (US) | 2007-10-10 | — | — | EP | claimed |
| CN-1893910-A | Cyclic siloxane compositions for active ingredient release | GEN ELECTRIC (US) | 2007-01-10 | — | — | CN | claimed |
| EP-1716159-A2 | CYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS | General Electronic Company (US) | 2006-11-02 | — | — | EP | claimed |
| EP-1697386-A1 | ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES | General Electric Company A Corporation of the State of New York (US) | 2006-09-06 | — | — | EP | claimed |
| WO-2005066187-A1 | ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES | GENERAL ELECTRIC COMPANY (US) | 2005-07-21 | — | — | WO | claimed |
| WO-2005066186-A2 | CYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS | GENERAL ELECTRIC COMPANY (US) | 2005-07-21 | — | — | WO | claimed |
| US-20050136021-A1 | Active-releasing cyclic siloxanes | MOMENTIVE PERFORMANCE MATERIALS INC. | 2005-06-23 | — | — | US | claimed |
| US-20050136022-A1 | Cyclic siloxane compositions for the release of active ingredients | MOMENTIVE PERFORMANCE MATERIALS INC. | 2005-06-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260083652-A1 | RENEWABLE ESTER EMOLLIENT FOR ENHANCED CUTANEOUS PERMEATION | ELOVL3, CRAT, ELOVL5 | DGKA 2073/4885MAPT 1314/4885DNM1 4747/4885 |
| US-20050136022-A1 | Cyclic siloxane compositions for the release of active ingredients | F9, RPL39, ECPAS | DGKA 3675/4885MAPT 815/4885DNM1 4837/4885 |
| US-20050136021-A1 | Active-releasing cyclic siloxanes | F9, RPL39, ALDH16A1 | DGKA 3785/4885MAPT 1453/4885DNM1 4844/4885 |
| US-20260028562-A1 | FLAVORED POROUS MATERIAL FOR FLAVORED BEVERAGE PRODUCTION | CD69, SORD, TAS2R13 | DGKA 819/4885MAPT 856/4885DNM1 4684/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.